Kestra Medical recently filed a form S-1 to confirm its intent to go public through an initial public offering (IPO).

Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

An automated implantable cardioverter defibrillator (ICD or AICD) is a permanent device in which a lead (wire) inserts into the right ventricle and monitors the heart rhythm. It is implanted ...

How are patients with myocardial scar after a myocardial infarction and ventricular tachycardia currently managed? Implantable cardioverter–defibrillators (ICDs) improve survival in patients ...

Kestra Medical Technologies announced today that it appointed Al Ford as its new chief commercial officer (CCO).

The first cardioverter-defibrillator, invented and developed by Polish-born Israeli-American physician Michel Mirowski, was implanted in a patient at Johns Hopkins Hospital. Since then ...